Skip to content
naulon
Not checkedNot checked for notices yet.

Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease

Xiao Ding, Xiaozhong Yang, Honggang Wang

Medicine in Microecology · 2020

doi:10.1016/j.medmic.2020.100028 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.

Abstract licence: CC BY-NC-ND

References117

  1. 14.
  2. 40.

38 more references, whose wording the paper’s licence keeps private.

All 117 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.